Literature DB >> 16334749

Whether or not prophylactic excision of the extrahepatic bile duct is appropriate for patients with pancreaticobiliary maljunction without bile duct dilatation.

T Kusano1, T Takao, K Tachibana, Y Tanaka, M Kamachi, Y Ikematsu, Y Nishiwaki, H Kida, S Waki, M Uchimura, M Furukawa.   

Abstract

BACKGROUND/AIMS: The standard treatment for patients with a pancreaticobiliary maljunction (PBM) without bile duct dilatation remains controversial.
METHODOLOGY: We followed up 29 patients with such PBM who mainly underwent a cholecystectomy alone. The ages of the patients ranged from 3 to 76 years (average age 47.3 years) and the ratio of males to females was 8 vs. 21. When the diameter of the common bile duct was less than 10mm, such bile ducts were diagnosed to have no dilatation. The main clinical indications for surgery were cholecystolithiasis in 15 patients, choledocholithiasis in 3, cholecystocholedocholithiasis in 2, gallbladder polyp in 2, adenomyomatosis in 2, cholecystitis in 2, and protein plug in 1.
RESULTS: The amylase levels of gallbladder bile in 20 patients ranged from 115 to 460,200 IU/mL (a mean of 191,698 IU/mL). One patient died of gastric cancer 182 months after surgery and two patients died of other diseases 153, 171 months after surgeries, respectively. The remaining 26 patients have all been doing well for 36 months to 326 months after surgery (a median follow-up period, 160.5 months). The 10- and 15-year survival rates were 100% and 89.7%.
CONCLUSIONS: In conclusion, a prophylactic resection of the extrahepatic bile duct and biliary diversion could be unnecessary for patients with PBM without bile duct dilatation.

Entities:  

Mesh:

Year:  2005        PMID: 16334749

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Japanese clinical practice guidelines for pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Hisami Ando; Masafumi Suyama; Mitsuo Shimada; Yuji Morine; Hiroshi Shimada
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

Review 2.  Diagnosis and treatment of pancreaticobiliary maljunction in children.

Authors:  Shigeru Ono; Shigehisa Fumino; Naomi Iwai
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

3.  Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.

Authors:  Akihiko Tsuchida; Takao Itoi
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

4.  Histological study of gallbladder and bile duct epithelia in patients with anomalous arrangement of the pancreaticobiliary ductal system: comparison between those with and without a dilated common bile duct.

Authors:  Yutaka Noda; Naotaka Fujita; Go Kobayashi; Kei Ito; Jun Horaguchi; Osamu Takasawa; Takashi Obana; Kazuhiko Ishida; Shigeharu Senoo; Makoto Yonechi; Takashi Suzuki; Dai Hirasawa; Toshiki Sugawara; Masao Kobari; Takashi Sawai; Miwa Uzuki; Mika Watanabe
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

5.  Type II congenital biliary dilation (biliary diverticulum) with pancreaticobiliary maljunction successfully treated by laparoscopic surgery: report of a case.

Authors:  Hiroshi Kono; Takao Ohtsuka; Minoru Fujino; Noboru Ideno; Teppei Aso; Yosuke Nagasyoshi; Yasuhisa Mori; Shunichi Takahata; Masafumi Nakamura; Toshiharu Ueki; Masao Tanaka
Journal:  Clin J Gastroenterol       Date:  2011-12-24

6.  Pancreaticobiliary reflux as a high-risk factor for biliary malignancy: Clinical features and diagnostic advancements.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2015-07-08

7.  Clinicopathologic Differences in Patients with Gallbladder Cancer According to the Presence of Anomalous Biliopancreatic Junction.

Authors:  Jihoon Chang; Jin-Young Jang; Mee Joo Kang; Woohyun Jung; Yong Chan Shin; Sun-Whe Kim
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.